These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 383236)

  • 21. THE NEW MEDICAL BUILDINGS OF THE UNIVERSITY OF TORONTO.
    Macallum AB
    Science; 1903 May; 17(438):813-7. PubMed ID: 17757496
    [No Abstract]   [Full Text] [Related]  

  • 22. The Treatment of the Pedicle in Ovariotomy: A Paper Read before the Canadian Medical Association at Toronto, Ont., August 2d, 1876.
    Strange FW
    Buffalo Med Surg J; 1876 Sep; 16(2):41-46. PubMed ID: 36663406
    [No Abstract]   [Full Text] [Related]  

  • 23. Extragenic Suppression of Elongation Factor P Gene Mutant Phenotypes in Erwinia amylovora.
    Klee SM; Sinn JP; Holmes AC; Lehman BL; Krawczyk T; Peter KA; McNellis TW
    J Bacteriol; 2019 Jun; 201(11):. PubMed ID: 30885930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting the pathway involved in post-translational modification of elongation factor P in a subset of bacterial species.
    Bailly M; de Crécy-Lagard V
    Biol Direct; 2010 Jan; 5():3. PubMed ID: 20070887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation and point of action of a factor from Escherichia coli required to reconstruct translation.
    Ganoza MC; Cunningham C; Green RM
    Proc Natl Acad Sci U S A; 1985 Mar; 82(6):1648-52. PubMed ID: 3885216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cloning, sequencing and overexpression of the gene for prokaryotic factor EF-P involved in peptide bond synthesis.
    Aoki H; Adams SL; Chung DG; Yaguchi M; Chuang SE; Ganoza MC
    Nucleic Acids Res; 1991 Nov; 19(22):6215-20. PubMed ID: 1956781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A proposed role for IF-3 and EF-T in maintaining the specificity of prokaryotic initiation complex formation.
    Ganoza MC; Cunningham C; Chung DG; Neilson T
    Mol Biol Rep; 1991 Feb; 15(1):33-8. PubMed ID: 1875917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of mutagenesis of Gln97 in the switch II region of Escherichia coli elongation factor Tu on its interaction with guanine nucleotides, elongation factor Ts, and aminoacyl-tRNA.
    Navratil T; Spremulli LL
    Biochemistry; 2003 Nov; 42(46):13587-95. PubMed ID: 14622005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification and properties of the heterogeneous subunits of elongation factor EF-1 from Guerin epithelioma cells.
    Marcinkiewicz C; Gajko A; Gałasiński W
    Acta Biochim Pol; 1991; 38(1):129-34. PubMed ID: 1796694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enacyloxin IIa, an inhibitor of protein biosynthesis that acts on elongation factor Tu and the ribosome.
    Cetin R; Krab IM; Anborgh PH; Cool RH; Watanabe T; Sugiyama T; Izaki K; Parmeggiani A
    EMBO J; 1996 May; 15(10):2604-11. PubMed ID: 8665868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of fMet-tRNAfMet, Met-tRNAfMet, and Met-tRNAmMet with bacterial elongation factor Tu:GTP complex: discrimination against fMet-tRNAfMet.
    Tanada S; Kawakami M; Takemura S
    Nucleic Acids Symp Ser; 1981; (10):165-8. PubMed ID: 7031610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of mitochondrial elongation factors Tu.Ts with aminoacyl-tRNA.
    Benkowski LA; Takemoto C; Ott G; Beikman M; Ueda T; Watanabe K; Sprinzl M; Spremulli LL
    Nucleic Acids Symp Ser; 1995; (33):163-6. PubMed ID: 8643359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and Best Department of Medical Research, University of Toronto, Ont., Canada.
    Glick BR; Green RM; Ganoza MC
    Can J Biochem; 1979 Jun; 57(6):749-57. PubMed ID: 383236
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.